Source:http://linkedlifedata.com/resource/pubmed/id/17714439
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2007-10-10
|
pubmed:abstractText |
Rice seed-based edible vaccines expressing T-cell epitope peptides derived from Japanese cedar major pollen allergens have been used to successfully suppress allergen-specific Th2-mediated immunoglobulin E (IgE) responses in mouse experiments. In order to further expand the application of seed-based allergen-specific immunotherapy for controlling Japanese cedar pollinosis, we generated transgenic rice plants that specifically express recombinant Cry j 1 allergens in seeds. Cry j 1 allergens give low specific IgE-binding activity but contain all of the T-cell epitopes. The allergens were expressed directly or as a protein fusion with the major rice storage protein glutelin. Fusion proteins expressed under the control of the strong rice endosperm-specific GluB-1 promoter accumulated in rice endosperm tissue up to 15% of total seed protein. The fusion proteins aggregated with cysteine-rich prolamin and were deposited in endoplasmic reticulum-derived protein body I. The production of transgenic rice expressing structurally disrupted Cry j 1 peptides with low IgE binding activity but spanning the entire Cry j1 region can be used as a universal, safe and effective tolerogen for rice seed-based oral immunotherapy for cedar pollen allergy in humans and other mammals.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Allergens,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Plant,
http://linkedlifedata.com/resource/pubmed/chemical/Cry j I protein, Cryptomeria...,
http://linkedlifedata.com/resource/pubmed/chemical/Glutens,
http://linkedlifedata.com/resource/pubmed/chemical/Plant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Prolamins,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1467-7652
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
815-26
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:17714439-Administration, Oral,
pubmed-meshheading:17714439-Allergens,
pubmed-meshheading:17714439-Antigens, Plant,
pubmed-meshheading:17714439-Blotting, Southern,
pubmed-meshheading:17714439-Cryptomeria,
pubmed-meshheading:17714439-Genetic Vectors,
pubmed-meshheading:17714439-Glutens,
pubmed-meshheading:17714439-Oryza sativa,
pubmed-meshheading:17714439-Plant Proteins,
pubmed-meshheading:17714439-Plants, Genetically Modified,
pubmed-meshheading:17714439-Prolamins,
pubmed-meshheading:17714439-Recombinant Fusion Proteins,
pubmed-meshheading:17714439-Seeds,
pubmed-meshheading:17714439-Vaccination
|
pubmed:year |
2007
|
pubmed:articleTitle |
Development of transgenic rice seed accumulating a major Japanese cedar pollen allergen (Cry j 1) structurally disrupted for oral immunotherapy.
|
pubmed:affiliation |
Transgenic Crop Research and Development Center, National Institute of Agrobiological Sciences, Kannondai 2-1-2, Tsukuba, Ibaraki 305-8602, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|